Publication | Closed Access

The development of a practical synthesis of the potent and selective somatostatin sst3 receptor antagonist [4-(3,4-difluoro-phenyl)-piperazine-1-yl]-{(4S,4aS,8aR)-2[(S)-3-(6-methoxy-pyridin-3-yl)-2-methyl-propyl]-decahydroisoquinoline-4-yl}-methanone (NVP-ACQ090)

Medicinal ChemistryPractical SynthesisBiochemistryMedicineNatural SciencesMechanism Of ActionPharmacological AgentPharmacotherapyNon-peptide LigandPharmacologyPharmaceutical ChemistryDrug Discovery